Fatigue assessment when treatment is started may be an early clinical marker of adverse event risk, the researchers suggested ...

A PSA of 127 indicated a high probability of prostate cancer, leading to immediate Lupron ADT therapy and radiation treatment ...

Men’s Health Thailand by Dr. Niti Navanimitkul For many men, a diagnosis of prostate cancer comes with two major worries: ...

The old belief that testosterone therapy increases prostate cancer or makes it worse is no longer backed up by modern ...

Prostate cancer is highly treatable when detected early, as it carries a favourable prognosis. Therefore, awareness among ...

Cancer of the prostate has become the leading cause of cancer diagnoses among males in the United Kingdom. Its treatment, ...

Prostate cancer is one of the most common cancers in men but often goes unnoticed. Experts stress early screening, awareness ...

Assessments used to calculate cardiovascular disease risk in the general population may not have the same predictive power ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

For patients with oligometastatic cancers, particularly kidney or prostate, stereotactic body radiotherapy may frequently ...

Nonlinear improvement seen in relative benefit of distant metastasis, OS, with reduced benefits beyond nine to 12 months of ADT.